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Abstract
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Background—Intracranial atherosclerotic disease (ICAD) is the most frequent subtype of ischemic stroke
globally. It is important to describe the determinants of early ICAD as a strategy to prevent strokes from
clinically evident and progressive ICAD. Our objective is to report the determinants of asymptomatic
ICAD by linking the presence or absence of ICAD on magnetic resonance angiogram (MRA) with detailed
risk assessment in asymptomatic adults.
Methods—This is an observational cross-sectional analytical study. We plan to recruit 200 adult partici-
pants from the radiology departments of two tertiary care centers of Karachi, Pakistan. The participants will
first be screened for the absence of stroke symptoms via the Questionnaire for Verifying Stroke Free Status
(QVSFS). QVSFS negative will be participants will be eligible. After written informed consent, partici-
pants will undergo detailed medical, sociodemographic, lifestyle, and anthropometric evaluation by a
detailed interview. They will, in addition, undergo MRA to study the presence, degree, and distribution of
asymptomatic ICAD. All MRA scans will be reviewed centrally by vascular neurologists blinded to clinical
information. These images would be reviewed on DICOM Viewer 3.0 used for calculating the degree of
stenosis using Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) study defined criteria
employing electronic calipers. A sample size of 200 will achieve 80% power for detecting a minimum dif-
ference of 20% in the prevalence of exposure factors (medical and lifestyle) between asymptomatic ICAD
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positive and ICAD negative persons. This study will generate regional data on risks for ICAD development
and prevention in a high-risk susceptible population.
Study ID: NCT02072876
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Background
Stroke is the emerging noncommunicable disease epi-
demic of the developing world. Studies from Pakistan,
the sixth most populous nation in the world [1], report
that the lifetime prevalence of cerebrovascular disease
(CVD) is one in four (25%) over the age of 35 years [2].
Two thirds of all stroke deaths now occur in low- and
middle-income countries that report a 100% increase in
the incidence of stroke in the last four decades [3].
Intracranial atherosclerotic disease (ICAD), which is
progressive narrowing of the arteries at the base of the
brain, is a major cause of ischemic stroke, with higher
prevalence in Asian, African American, and Hispanic
individuals as compared with Caucasians [4]. ICAD
causes about 30%–50% of ischemic strokes among
Figure 1. Study flow diagram.
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patients of Asian ancestry, by contrast, approximately
8%–9% of strokes are attributable to ICAD in Caucasi-
ans [5].The Karachi Intracranial Stenosis study (KISS),
a hospital-based case–control study for symptomatic
ICAD, reported that 80% of vessels studied in stroke
patients had significant asymptomatic stenosis (>70%)
[6].
Numerically, symptomatic ICAD is the most common
mechanism of stroke in the world, given that a large part
of the world’s population lives in Asia. Clinical ICAD is
likely to be preceded by a period of silent atherosclerotic
narrowing and plaque formation. At the point of either
critical stenosis, or plaque destabilization, strokes result
from loss of blood supply, overlying thrombosis and/or
arterial embolization [7].Clinical ICAD is an aggressive
disease. The rate of stroke recurrence is high (up to
18%–24% annually) [4], [8]. Current interventions for
clinically active ICAD are difficult to implement in
regions that bear the brunt of ICAD [9]–[11]. Our over-
arching rationale is that early detection of asymptomatic
ICAD and identification of its risk factors may allow
regionally implementable therapeutic interventions at a
lower cost and greater efficacy. We feel this is impor-
tant, since this is a unique population subject to an
increased risk of stroke mortality [12] that has increased
in the last decade and is a call for action.
Objective
Our objective is to study the clinical, lifestyle, dietary,
and psychosocial determinants of asymptomatic ICAD
in clinically normal adults. As an additional secondary
objective, we will also study the frequency of ICAD-
associated findings on magnetic resonance imaging
(MRI), e.g., brain volume reduction, silent brain infarcts,
and periventricular hyper intensities in patients diag-
nosed with asymptomatic ICAD on MRI brain. We
hypothesized that there is at least a 20% difference in
the proportion of clinical, lifestyle (dietary, physical
activity, obesity, smoking, and stress/depression), and
socioeconomic predictors among asymptomatic ICAD
patients than those with no ICAD.
Methods
Study Design
Analytical Cross-Sectional Observational Study (Figure
1, Flow Chart)
Study Setting
The study will be carried out at the radiology depart-
ments of two major tertiary care centers in Karachi,
Pakistan [Aga Khan University (AKU)], and Dow Uni-
versity of Health Sciences (DUHS). These major MRI
centers cover the bulk of MRI referrals from all over
Pakistan and cover all socioeconomic and ethnic strata.
AKU is a private not for profit academic international
center. The Dow University Radiology Center is a pub-
lic sector, government funded, subsidized-at-cost center.
Both the centers have radiology departments equipped
with 1.5 Tesla MRI scanner facilities, which are open
24/7 for all patients (inpatients and outpatients). Since
both are based in Karachi, Pakistan’s largest city with a
mix of ethnicities, together they represent a microcosm
of Pakistan, and provide a wide spectrum of participants
that lends representativeness to the sample population.
Study Population
This study aims to recruit adult Pakistani patients > 18
years, with no previous clinical history of stroke (nega-
tive on QVSFS), presenting to the two tertiary care cen-
ters for MRI brain for indications other than stroke (e.g.,
nonspecific headache, sinusitis, primary epilepsy, and
primary dementia without stroke history) and consenting
for MRA, interview, and anthropometry.
Sample Size Estimation
We have calculated that a minimum sample size of 200
people will be required in order to achieve 80% power
for detecting a minimum difference of at least 20% in
the prevalence of exposure factors (medical and life-
style) between asymptomatic ICAD positive and ICAD
negative persons, with the anticipated prevalence of all
exposure factors (medical: diabetes, hypertension, dysli-
pidemia, and heart disease; and lifestyle: dietary, physi-
cal activity, obesity, and stress) ranging from 4%–70%,
assuming a 1:3 ratio in patients with ICAD versus no
ICAD at a 5% level of significance.
Statistical Analysis
For continuous variables like age, weight, height, waist
circumference and body mass index (BMI), mean and
standard deviations (SDs) will be calculated. For catego-
rical variables like gender, ethnicity, education, marital
status, income, occupation, ICAD, clinical and lifestyle
factors (diabetes, hypertension, dyslipidemia, CVD,
tobacco use, obesity, diet, and depression), brain atro-
phy, silent brain infarcts, and perventricular lucencies,
proportions will be calculated.
BMI will be calculated by dividing weight in kilogram
by the square of height in square meters. BMI was
expressed as mean and SD as well as five categories
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defined using the South Asian cutoffs [13]. Waist cir-
cumference was also divided into categories using cut-
offs defined specifically for Asians [14].
The independent contribution of any risk factor to ICAD
will be examined in the univariate Cox proportional haz-
ards model, which was used to calculate prevalence
ratios. Point estimates and 95% confidence intervals
(CIs) were calculated from the regression coefficients.
The p value of the Wald statistics for each explanatory
variable was used for assessing its coefficient with sig-
nificance of 0.25.
In order to compute the statistically adjusted prevalence
ratios (PR), multivariable Cox regression analysis will
be done. Variables will be introduced as continuous or
categorical variables, as indicated in results. With cate-
gorical variables, the lowest or opposite category will
serve as the reference group. All the variables significant
at univariable level and/or the variables with previously
known associations with the outcome (ICAD) will be
entered into the model in a block wise fashion. The level
of significance of ≤0.05 was set for multivariable analy-
sis. Significance of each individual independent variable
was assessed by its Cl, Wald statistic and the change in
the −2 log-likelihood. Insignificant variables (p > 0.05)
were removed one by one from the model with the most
insignificant first after checking their interaction. A final
model was recalculated as the most parsimonious ver-
sion, including only significant variables and interpreted
by using adjusted PRs and their 95% CIs. Statistical
analyses were conducted using the Statistical Package
for Social Sciences (SPSS), Version 19.
Study Inclusion and Exclusion
Criteria
Inclusion Criteria:
• Adult Pakistani men and women ≥18 years of
age getting MRI brain for any indication other
than stroke.
• Permanent residents of Pakistan for at least 1
year.
• No prior history of stroke confirmed by screen-
ing with QVSFS. QVSFS negative.
• Able to give written informed consent.
Exclusion Criteria:
• QVSFS positive
• Severe disability, life expectancy less than 6
months at enrollment
• Patients in whom MRI prolongation for 5
minutes can be harmful for the patient (Anes-
thesia, claustrophobia, sedation, and so on)
• Any clear contraindications to MRI, e.g., pace-
makers, metallic valves, patient is not an MRI
candidate
Study Procedures
Prefield Pilot
The questionnaire has been translated from English into
Urdu. The aim was not to do a literal word to word
translation but to have conceptually equivalent items in
the Urdu version of the questionnaires as well as to
insert culturally acceptable terms particularly for the diet
questionnaire. Already the existing and validated Urdu
versions of Short International Physical Activity Ques-
tionnaire (IPAQ) and Self-Reporting Questionnaire
(SRQ) for depression [15] and tested Urdu version of
QVSFS will be used [2], [16], [17]. The rest of the ques-
tionnaire has been translated into Urdu by the principal
investigator (PI) directly for quality and conceptualiza-
tion. The Urdu version of the questionnaire will then be
pretested in the neurology clinic population (10% of the
sample size) to see its acceptability after which any
required changes in the phrasing of Urdu version of the
questionnaire will be done.
Hiring and Training Data Collectors
Before the start of the data collection process, the data
collectors will be given training on communication
skills through a two day long workshop conducted by
the PI. They will be introduced to the different tools
used in the questionnaire and their administration. They
will also be given training on how to perform anthropo-
metric measurements. Along with this they will also be
given a copy of the Manual of operations (Additional
File 1) specifying pictorial methods for anthropometric
measurements. A standard method of data reporting will
be communicated to all. No box or space in the form is
to be left blank and if left blank the reason has to be
specified in the form. Training will also include visit to
the specified settings to orient the data collectors to the
place and introduce them to the relevant people whom
they might encounter during the data collection process.
The data collectors will be taught to keep records of all
patients they approach whether they get enrolled in the
study or not. Once training is complete the data collec-
tors will be cross-checked by the PI in the field at the
site for audit and feedback.
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Data Collection Procedures
Nonprobability purposive sampling will be used to
recruit consecutive patients prospectively from the two
hospital sites. Data collectors at the two field sites will
be responsible for first screening out all outpatients who
come for MRI brain, via QVSFS, for presence of stroke
and then take informed consent and enroll them in the
study. Once the participant is recruited in the study, the
research officers will collect history of medical and life-
style factors on a SRQ consisting of seven sections (as
detailed below) followed by height, weight, and waist
measurements and imaging study. These images will
then be collected on compact disks (CDs) by the desig-
nated research officers for centralized image viewing.
All data forms coming from the field shall be checked
by the PI and discrepant or unfilled forms will be
returned for completion. To ensure data accuracy, we
will perform double data entry by a data entry officer
who has been trained by the PI in reading the filled data
forms using the data code book. (Additional File 2
(Questionnaire)).
Data Collection Tools and Variable
Definition
Following data collection tools will be used in this
study:
I. Questionnaire (Additional File 2) consisting of
eight sections is as follows:
1. Screening questionnaire for stroke
(QVSFS) [2], [6]
2. Demographic and Socioeconomic Informa-
tion via World Bank Wealth Index [18]
3. Clinical risk factors
4. Tobacco usage [19]
5. IPAQ short form for physical activity
assessment (Additional File 3) [20]
6. Food frequency Questionnaire (FFQ) [21],
[22]
7. Self-Reporting Questionnaire (SRQ) for
depression [15], [23]
8. Anthropometric measurements [13]
II. MRI Brain with MRA
III. Data Collection Form (DCF) (Additional File
3) for detecting intracranial stenosis [24], [25]
Questionnaire
The questionnaire consists of eight sections. Section I is
the stroke free status determining questionnaire, which
is an important inclusion criterion for the study. It is an
eight-item structured questionnaire originally designed
to identify study subjects, who are free of symptomatic
cerebrovascular disease, with a high sensitivity (0.97)
and moderate specificity (0.60) for detecting stroke [26].
It has been used in previous studies on Pakistani popula-
tion and has a good detection rate [6]. Section II is the
demographic and socioeconomic information section. It
has 10 items that collect information about age, sex, eth-
nicity, education, and marital status and five questions
regarding income, occupation, and number of household
members and household assets. For assessing household
assets, the Assets Questionnaire developed by the World
Bank for developing countries will be used [18]. The
questionnaire has been modified keeping in view the
study population. It consists of 19 items inquiring about
the presence or absence of household assets, and the
number of persons sharing a room. Section III inquires
about clinical risk factors, e.g., diabetes, hypertension,
dyslipidemia, heart attack, atrial fibrillation, and history
of coronary bypass surgery. Hypertension is defined as
systolic blood pressure > 140 mmHg or diastolic blood
pressure > 90 mmHg, or those with a clear hypertension
medical record, or record of antihypertensive drugs
usage [27]. Subjects with diabetes mellitus are those
with documented diabetes in the medical record, or
those having a random glucose level of >11.1 mmol/L
(200 mg/dl) or those who are on medicines for diabetes
treatment [28]. Dyslipidemia is defined as total choles-
terol >200 mg/dl or LDL >160 mg/dl or those taking
lipid-lowering drugs [29], [30]. IHD is defined as a
known history of myocardial infarction or angina [29].
Section IV has the World Health Organization (WHO)
stepwise approach to surveillance (STEPS) question-
naire for tobacco usage [19]. It has 13 items collecting
self-reported information of current or past smoking and
smokeless tobacco use with durations. Current users are
defined as individuals who have been using any kind of
tobacco in the previous 12 months. Former users are
those who have quit more than a year earlier. Section V
is the IPAQ short form. It has seven items that collect
information regarding time spent in vigorous, moderate
physical activity, walking, and sitting during the last
week [31]. Section VI is the dietary questionnaire that
collects information on the daily, weekly, and monthly
consumption of food items and their quantity using a
Food Frequency Questionnaire designed especially for
the study keeping in mind the culinary pattern of the
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common Pakistani. It has 11 sections collecting informa-
tion on 62 items.(Bread, Cereals, dairy products, Rice,
lentils, meat ,Bar BQ, Curries, Fish, Fruits and vegeta-
bles and bakery items) [21]. Section VII is the SRQ for
depression [15]. This standardized screening instrument
measures psychological and somatic symptoms associ-
ated with depression through 20 items. Each item has a
yes/no answer. The time span refers to the individual's
feelings over the past 30 days. Each item is scored 0 or
1. The maximum score is therefore 20. Its validity has
been tested in Pakistani population and found to have
good psychometric properties with sensitivity of 78%
and specificity of 81% [32].
Section VIII is the anthropometric measurements sec-
tion. This includes measurement of body weight of the
individual in kilograms and height and waist measure-
ment in centimeters to calculate BMI. These anthropo-
metric indices are regarded as the measurement of gen-
eral and central obesity. For categorizing BMI, WHO’s
recommendations for Asian population will be used.
According to this classification, ≤18.5 kg/m2is under-
weight, 18.6–22.9 is normal weight, 23–24.9 is pre over-
weight, 25–29.9 is overweight, and >30 kg/m2 is obese
[13].
Waist circumferences of ≥90 cm in men and ≥80 cm in
women have been taken as cutoffs for increased risk of
metabolic consequences [14].
We presume the questionnaire will take around 30
minutes for administration.
Section II is the phase where the patient will undergo
MRI brain along with an additional 5 minutes MRA
without contrast administration.
Section III consists of the Questionnaire for document-
ing intracranial stenosis. It has seven questions regard-
ing brain tissue volume, periventricular lucencies, old
vascular lesions, and nonstroke lesions along with a
table documenting the degree of stenosis in each cere-
bral vessel. Information will be collected for a total of
19 vessels per scan. A standardized MRI reading form
adapted from the work of J Wardlaw will be used [33]–
[38].
MRA Evaluation of Intracranial
Stenosis
This is defined as any artery (internal carotid artery,
middle cerebral artery, anterior cerebral artery, posterior
cerebral artery, basilar artery, and vertebral artery) hav-
ing >25% stenosis on MRA. An internationally standar-
dized equation will be used to calculate the degree of
stenosis. This method has also been used successfully in
a Pakistani study [39] to measure symptomatic intracra-
nial stenosis.
Percent stenosis = [1 − (Dstenosis/Dnormal) × 100], where
Dstenosis is the diameter of the artery at the site of the
most severe stenosis, and Dnormal = diameter of the
proximal normal artery [40].
Special freely available software DICOM Viewer 3.1
will be used to save all MRI images. It allows zooming,
panning, measurements, annotations, and segmentation
of the images. It has the ability to rotate (90°, 180°) and
flip (horizontal, vertical) images. It also provides one
with angle values, which helps in measuring stenosis
around corners. All opened images can be reported
simultaneously. All MRI CDs will be reviewed by a vas-
cular neurologist and radiologist team intracranial occlu-
sive lesions will be rated by giving them 1 of 5 grades
depending on the narrowness of the arteries [41].
• <25%, Atherosclerotic irregularity
• 25%–49% reduction as mild stenosis
• 50%–74% reduction as moderate stenosis
• 75%–99% reduction as severe stenosis
• No opening will be graded as complete occlu-
sion
Additionally, the MRI brain will also be viewed for the
presence of brain atrophy, periventricular lucencies, old
strokes and nonstroke lesions, and coded on a standar-
dized form [33], [41], [42].
Ethical Concerns
The study protocol has been approved by the Ethical
Review Committees (ERC) of both participating centers.
(ERC number 2327 CHS ERC 12, and IRB 360/DUHs
2012). All participants will provide a written informed
consent. All MRA scans are reviewed within 24 hours
by radiology teams with a provision in the study to
report any critical, life threatening incidental findings
like aneurysms to the referring physician and provision
of urgent referral to facilitate care. In addition, all key
study and field staff received training in Neuroethics,
Good Clinical Practice (GCP), informed consent proce-
dures, and human subject’s protection in research.
Discussion
This study will demonstrate the distribution and deter-
minants of ICAD in otherwise normal asymptomatic
Kamal et al. 32
Journal of V
ascular and Interventional N
eurology, V
ol. 8
Pakistanis presenting for MRI without a history of prior
stroke. Available international data reports ICAD preva-
lence of 4%–29% in high-risk asymptomatic subjects
[43]–[45]. The range of ICAD varies from 3% to 29.6%
depending on the modality used; cutoffs and risk pro-
files of population. Most of these previous studies [46]–
[54] have preferentially selected high-risk individuals to
study the prevalence of asymptomatic ICAD, however
none have been performed in Pakistan and most have
used transcranial doppler (TCD) or a single artery
instead of a more holistic approach. Other serious limita-
tions of previous investigations are inappropriate recruit-
ment strategies, evaluating only one artery, or choosing
to report only advanced stenosis, or selecting high-risk
patients likely to have strokes. Information on all life-
style predictors like exercise, diet, smoking, obesity,
stress of ICAD have to date not been described,
although known risks like hypertension, diabetes, and
previous stroke have been inconsistently reported.
This study plans to recruit relatively risk free individuals
and hopes to uncover social and demographic determi-
nants of ICAD that have not been previously investiga-
ted. Regional comparable data for risk free subjects is
sparse. Since we are using a sensitive modality like
MRI, we hope to accurately detect the presence of ICAD
better as compared to studies reported that have
employed TCD for the same.
We feel that our study design is valuable for the follow-
ing reasons. We will not select high-risk participants
with hypertension, diabetes, and so on; therefore, bias-
ing our study toward conventional risk factors alone. A
detailed review of asymptomatic status shall be done
using a questionnaire (QVSFS), which has been used
internationally to rule out clinical stroke with 95% sensi-
tivity and specificity [55]. This has been previously used
in Pakistan [2]. In addition, all our risk factor assess-
ment tools have been locally validated [15], [24]. Rigor-
ous training will be given to all data collectors, so that
the same protocol is implemented at all centers. 24/7
back up was available for any participant intake, where
there was a question about stroke, by stroke neurologists
further adding clarity to participant eligibility. Same
diagnostic MRI, i.e., 1.5 Tesla was used at both the cen-
ters thus reducing diagnostic/detection bias. Centralized
coding system for MRA and specialized software was
used for storing and image viewing with expert back up.
This study assessed a number of novel risk factors for
ICAD like sociodemographic factors, physical activity,
diet, and depression, which have not been explored pre-
viously, i.e., a whole person approach rather than focus-
ing on only traditional vascular risk factors like hyper-
tension, diabetes, and so on. This approach for ICAD is
comprehensive. This knowledge will inform both global
and local stroke preventive strategies of the most com-
mon cause of stroke in the world.
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